3
as a broad quartet (5JHF ~ 1.0 Hz) due to spin-spin interactions
with the fluorine atoms of the CF3 group. This suggests that the
C–C bond in the fragment С=С–С=О in the compound 5 exists in
Scheme 5. Mechanistic pathways for the aza-annulation of
enaminoketones with acryloyl chloride.
In conclusion, we have developed a facile and versatile
method for the synthesis of 5-trifluoroacetyl-3,4-dihydro-2(1H)-
pyridinones, which are potentially biologically active
compounds, and which could be potentially used in the design of
novel analogues for structure-activity research. They are also
precursors for fluorine-containing piperidines, pyridines, natural
alkaloids and other compounds.
1
s-E conformation. The H NMR spectrum of the mixture 6 and 7
showed three characteristic doublets of doublets at 6.0 (2JНН
=
1.6 Hz, 3JНН = 10.5 Hz), 6.5 (2JНН = 1.6 Hz, 3JНН = 16.8 Hz) and
6.8 (3JНН = 10.5, 16.8 Hz) which were assigned to the vinyl
protons of compound 6. The methylene groups of 7 appeared as
two triplets at 3.1 and 3.9 (3JНН = 6.5 Hz). The С=С double
bond of compounds 6 and 7 has the E-configuration (3JНН
~
13 Hz), which is characteristic of N,N-disubstituted fluorinated
enaminones.13 The structures of dihydropyridinones 3a-j and 5
were also confirmed by X-ray analysis of 6-methyl-1-(4-
methylphenyl)-5-(trifluoroacetyl)-3,4-dihydro-2(1H)-pyridinone
(3d) (Figure 1).14
Acknowledgments
We are grateful to ENAMINE Ltd, Kyiv, for providing NMR
spectra and to Dr. O. V. Shishkin, STC ‘Institute for Single
Crystals’, Kharkiv, for performing the X-ray diffraction study.
References and notes
1.
(a) Jones, T. H.; Blum, M. S. In Alkaloids: Chemical and
Biological Perspectives; Pelletier, S. W., Ed.; Wiley: New York,
1983; Vol. 1, Chap. 2. (b) Fodor, G. B.; Colaamti, B. In Alkaloids:
Chemical and Biological Perspectives; Pelletier, S. W., Ed.;
Wiley: New York, 1985; Vol. 31, Chapter 1. (c) Daly, J. W. J.
Nat. Prod. 1998, 61, 162. (d) Rubiralta, M.; Giralt, E.; Diez, A. In
Piperidine: Structure, Preparation, Reactivity and Synthetic
Applications of Piperidine and its Derivatives; Elsevier:
Amsterdam, 1991.
2.
(a) Karpov, A. S.; Oeser, T.; Muller, T. J. Chem. Commun. 2004,
1502; (b) Karpov, A. S.; Rominger, F.; Muller, T. J. J. Org.
Biomol. Chem. 2005, 3, 4382; (c) Eles, J.; Kalaus, G.; Greiner, I.;
Kajtar-Peredy, M.; Szabo, P.; Szabo, L.; Szantay, C. Tetrahedron
2002, 58, 8921.
Figure 1. X-ray structure of 6-methyl-1-(4-methylphenyl)-5-
(trifluoroacetyl)-3,4-dihydro-2(1H)-pyridinone (3d).
3.
4.
5.
Lesher, G. Y., Singh, B., Carabateas, Ph. M. US Patent 4,431,651,
1984; Chem. Abstr. 1984, 100, 174679.
Winters, G., Sala, A. EP 90275 A2, 1983; Chem. Abstr. 1984, 100,
85678.
Extended heating of the mixture 6 and 7 in pure chloroform or
in the presence of an equimolar quantity of pyridine did not yield
the pyridinone 5. This fact confirms the general view of the aza-
annulation reaction mechanism. We believe that electron-
donating substituents at the β-position in compounds 2a-j play an
important role in decreasing the activation barrier in the Michael
addition to acryloyl chloride, whereas for the less electron-rich
enaminone 4 the N-acylation reaction becomes competitive
(Scheme 5).
(a) Corriu, R. J. P., Perz, R. Tetrahedron Lett. 1985, 26, 1311; (b)
Barluenga, J.; Jardon, J.; Gotor, V. Synthesis 1988, 146; (c)
Marugen, M. M.; Martin, N.; Seoane, C.; Soto J. L. Liebigs Ann.
Chem. 1989, 2, 145; (d) Barluenga, J.; Tomas, M.; Suarez-
Sorbrino, A.; Gotor, V. Tetrahedron Lett. 1988, 29, 4855; (e)
Iwao, O.; Anna, K. Tetrahedron Lett. 1989, 30, 6283; (f) Meyers,
A. I.; Garcia-Munoz, G. J. Org. Chem. 1964, 29, 1435; (g) Duran,
F.; Ghosez, L. Tetrahedron Lett. 1970, 3, 245; (h) Sain, B;
Baruah, J. N.; Sandhu, J. J. Chem. Soc., Perkin Trans. 1 1985, 4,
773.
(a) Murphy, J. P.; Hadden, M.; Stevenson, P. J. Tetrahedron 1997,
53, 11827; (b) Chowdhury, S. K. D.; Sarkar, M.; Chowdhury, S.
R.; Mahalanabis, K. K. Synth. Commun. 1996, 26, 4233; (c)
Paulvannan, K.; Stille, J. R. J. Org. Chem. 1994, 59, 1613; (d)
Beholz, L. G., Benovsky, P., Ward, D. L., Barta, N. S., Stille, J. R.
J. Org. Chem. 1997, 62, 1033; (e) Chakrabarti, S.; Panda, K.;
Misra, N. C.; Ila, H.; Junjappa, H. Synlett 2005, 1437; (f)
Lyubchanskaya, V. M.; Sarkisova, L. S.; Alekseev, L. M.; Granik
V. G. Pharm. Chem. J. 1994, 28, 70. (g) Schirok, H.; Alonso-
Alija, C.; Michels, M. Synthesis 2005, 3085. (h) Benovsky, P.;
Stille, J.R. Tetrahedron Lett. 1997, 38, 8475;
(a) Welch, J. T.; Eswarakrishnan, S., Ed. In Fluorine in
Bioorganic Chemistry; Wiley: New York, 1991; (b) Filler, R.;
Kobayashi, Y.; Yagupolskii, L. M., Ed. In Organofluorine
Compounds in Medicinal Chemistry and Biochemical
Applications; Elsevier: Amsterdam, 2000; (c) Hiyama, T. In
Organofluorine compounds; Springer: Berlin, 2000; (d) Pondee,
R.; Liu, H. Bioorg. Chem. 2004, 32, 393; (e) Begue, J.-P.; Bonnet-
Delpon, D. J. Fluorine Chem. 2006, 127, 992; (f) Kirk, K. L. J.
Fluorine Chem. 2006, 127, 1013.
H3C
H
6.
O
N
Cl
+
R
O
CF3
R = H, Alk, Ar
R = H
Cl
H
H3C
N
O
Cl
N
O
H
H3C
7.
R
O
CF3
O
CF3
-HCl
-HCl
O
O
H3C
H3C
R
8.
9.
(a) Kacharova, L. M.; Gerus, I. I.; Kacharov, A. D. J. Fluorine
Chem. 2002, 117, 193; (b) Nenaidenko, V. G.; Sanin, A. V.;
Balenkova, E. S. Russ. Chem. Rev. 1999, 68, 483.
For typical procedures for the preparation of enaminones 2a-j and
4, see: (a) Hojo, M.; Masuda, R.; Okada, E.; Sakaguchi, S.;
Narumiya, H.; Morimoto, K. Tetrahedron Lett. 1989, 30, 6173; (b)
Gerus I.I., Gorbunova M.G., Vdovenko S.I., Yagupolskii Y.L.,
Kukhar V.P. Zh. Org. Khim., 1990, 26, 1877; (c) Lyutenko N.V.,
N
O
N
O
CF3
CF3
6
3